Your browser doesn't support javascript.
loading
Predicting the presence of colon cancer in members of a health maintenance organisation by evaluating analytes from standard laboratory records.
Goshen, Ran; Mizrahi, Barak; Akiva, Pini; Kinar, Yaron; Choman, Eran; Shalev, Varda; Sopik, Victoria; Kariv, Revital; Narod, Steven A.
Afiliação
  • Goshen R; Medial Early Sign, Kfar Malal, Israel.
  • Mizrahi B; Medial Research, Kfar Malal, Israel.
  • Akiva P; Medial Research, Kfar Malal, Israel.
  • Kinar Y; Medial Research, Kfar Malal, Israel.
  • Choman E; Medial Early Sign, Kfar Malal, Israel.
  • Shalev V; Institute of Health Research and Innovation, Maccabi Healthcare Services, Tel-Aviv, Israel.
  • Sopik V; Familial Breast Cancer Research Unit, Women's College Research Institute, Women's College Hospital, 76 Grenville Street, 6th Floor, Suite 6420, Toronto, ON, Canada M5S 1B2.
  • Kariv R; Department of Gastroenterology, Souraski Medical Centre, Tel-Aviv, Israel.
  • Narod SA; Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Br J Cancer ; 116(7): 944-950, 2017 Mar 28.
Article em En | MEDLINE | ID: mdl-28253525
BACKGROUND: A valid risk prediction model for colorectal cancer (CRC) could be used to identify individuals in the population who would most benefit from CRC screening. We evaluated the potential for information derived from a panel of blood tests to predict a diagnosis of CRC from 1 month to 3 years in the future. METHODS: We abstracted information on 1755 CRC cases and 54 730 matched cancer-free controls who had one or more blood tests recorded in the electronic records of Maccabi Health Services (MHS) during the period 30-180 days before diagnosis. A scoring model (CRC score) was constructed using the study subjects' blood test results. We calculated the odds ratio for being diagnosed with CRC after the date of blood draw, according to CRC score and time from blood draw. RESULTS: The odds ratio for having CRC detected within 6 months for those with a score of four or greater (vs three or less) was 7.3 (95% CI: 6.3-8.5) for men and was 7.8 (95% CI: 6.7-9.1) for women. CONCLUSIONS: Information taken from routine blood tests can be used to predict the risk of being diagnosed with CRC in the near future.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Sistemas Pré-Pagos de Saúde / Técnicas de Laboratório Clínico / Detecção Precoce de Câncer / Registros Eletrônicos de Saúde Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Sistemas Pré-Pagos de Saúde / Técnicas de Laboratório Clínico / Detecção Precoce de Câncer / Registros Eletrônicos de Saúde Idioma: En Ano de publicação: 2017 Tipo de documento: Article